Palivizumab - Synagis; MEDI-493; respiratory syncytial virus (RSV) monoclonal antibody, recombinant -- Product Record

RSV Mab, rDNA

    Nomenclature:
      RSV Mab1, rDNA [BIO]
      Synagis [TR]
      Palivizumab [FDA USAN INN]
      MEDI-493 [SY]
      respiatory syncytial virus (RSV) monoclonal antibody, humanized [SY]
      60574-4111-01 [NDC]

    molecular weight (kDa) = 148

    FDA Class:  Biologic BLA

    Year of approval (FDA) = 1998